A previous study showed that IL-6 and IL-12B inflammatory mediators were chronically elevated in leprosy patients who developed COVID-19.[4] Leprosy patients represent a vulnerable population that needs attention.[30,31]. The gene discussed is IL6; the disease is leprosy.